leisure time -WSS

leisure time

author：Wikipedia 2025-09-03 05:26:19 - browse：47367

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： For one rare type of lung cancer, Pfizer pill reduces progression by 81%

WSS

ASCO: AstraZeneca says CAR

J&J to emphasize cancer drugs, stop much of its vaccine research

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Takeda, Janssen join wearable maker to measure scratching

FDA investigates CAR

NIH documents show early flaws of $1.6 billion long Covid program

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

How to save PrEP access — and even expand it

Kaiser's Risant Health gobbled up Geisinger. Who is next?

After affirmative action ruling, medical educators look to 'holistic review'

CDC director unscathed in first congressional testimony

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

J&J to emphasize cancer drugs, stop much of its vaccine research

Continuity nursing helped my family in our darkest PICU moments

Pediatric cancer treatments threatened by a new FDA policy

Wikipedia

Flagship Pioneering launches a new biotech in two countries

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Organ aging and disease risk measured by new blood test

30 years of 'Listening to Prozac'

FDA investigates CAR

CDC director unscathed in first congressional testimony

hotspot

leisure time

entertainment

focus